Skip to main content
Log in

Reserpine, hydrochlorothiazide and pituitary-gonadal hormones in hypertensive patients

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Sex histories and serum samples were obtained from 27 hypertensive men before and after 3 months of therapy with either 100 mg of hydrochlorothiazide or 0.25 mg of reserpine daily. Sera were analyzed for testosterone, dihydrotestosterone, estradiol, luteinizing hormone and prolactin. Both drugs effectively lowered blood pressure. The incidence of impaired sexual performance was low and insignificantly different in the two treatment groups. There were no significant changes in serum hormone concentrations as a result of drug therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hollander W, Wilkins RW (1966) The pharmacology and clinical use of rauwolfia, hydralazine, thiazides, and aldosterone antagonists in arterial hypertension. Prog Cardiovasc Dis 8: 291–318

    Google Scholar 

  2. Bulpitt CJ, Dollery CT (1973) Side effects of hypotensive agents evaluated by a self-administered questionaire. Br Med J 3: 485–490

    Google Scholar 

  3. Veterans Administration Cooperative Study Group on Antihypertensive Agents (1962) Double-blind control study of antihypertensive agents: III. Chlorothiazide alone and in combination with other agents, preliminary results. Arch Intern Med 110: 230–236

    Google Scholar 

  4. Tuchmann-Duplessis H (1956) Influence de la reserpine sur les glandes endocrines. Presse Med 64: 2189–2192

    Google Scholar 

  5. Furuyama S, Mayes DM, Nugent CA (1970) A radioimmunoassay for plasma testosterone. Steroids 16: 415–428

    Google Scholar 

  6. McCann SM (1977) Luteinizing-hormone-releasing-hormone. N Engl J Med 296: 797–802

    Google Scholar 

  7. Sharp PJ (1975) The effect of reserpine on plasma LH concentration in intact and gonadectomized domestic fowl. Br Poult Sci 16: 79–82

    Google Scholar 

  8. Coppola JA, Leonardi RG, Lippmann W (1966) Ovulatory failure in rats after treatment with brain norepinephrine depletors. Endocrinology 78: 225–228

    Google Scholar 

  9. Turkington RW (1972) Prolactin secretion in patients treated with various drugs. Arch Intern Med 130: 349–354

    Google Scholar 

  10. Lee PA, Kelly MR, Wallin JD (1976) Increased prolactin levels during reserpine treatment of hypertensive patients. J Amer Med Assoc 235: 2316–2317

    Google Scholar 

  11. Gibb WE, Turner P, Malpas JS, White RJ (1970) Comparison of bethanidine, α-methyldopa, and reserpine in essential hypertension. Lancet 2: 275–277

    Google Scholar 

  12. Veterans Administration Cooperative Study Group on Antihypertensive Agents (1972) Effects of treatment on morbidity in hypertension: III. Influence of age, diastolic pressure, and prior cardivascular disease; further analysis of side effects. Circulation 45: 991–1004

    Google Scholar 

  13. Veterans Administration Cooperative Study Group on Antihypertensive Agents (1977) Propranolol in the treatment of essential hypertension. J Amer Med Assoc 237: 2303–2310

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boyden, T.W., Nugent, C.A., Ogihara, T. et al. Reserpine, hydrochlorothiazide and pituitary-gonadal hormones in hypertensive patients. Eur J Clin Pharmacol 17, 329–332 (1980). https://doi.org/10.1007/BF00558444

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00558444

Key words

Navigation